MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0004365
KBD Pharmaceuticals Private Limited
KBD Pharmaceuticals Private Limited - real estate in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹13.15 Lakh
▲ 10% YoY
Net profit · FY 2023
₹72,090
Net margin 5.5%
EBITDA · FY 2023
₹1.07 Lakh
EBITDA margin 8.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Last financials
Mar 2023
Balance sheet date
About KBD Pharmaceuticals Private Limited
Data last updated:
KBD Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 09 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U70100TG2014PTC096730.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Singh and Sharma Infra Private Limited. It is led by directors Puja Jyoti Kumari and Barun Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 1 – 2 – 212/1/C/3 Street No.11 Domalguda Suraj Nagar, Hyderabad, Telangana, India – 500029.
As per the financials filed for FY 2023, the company reported a revenue of ₹13.15 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹72,090 (net margin 5.5%) and EBITDA of ₹1.07 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 72% over three years and 80% over five years.
KBD Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0004365). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U70100TG2014PTC096730
Registration Number 096730
Incorporation Date 09 December 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0004365
Key People
Puja Jyoti Kumari Director Barun Kumar Director Recognitions & Rankings of KBD Pharmaceuticals
Contact details
KBD Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 – 2 – 212/1/C/3 Street No.11 Domalguda Suraj Nagar, Hyderabad, Telangana, India – 500029
- IndustryReal Estate, Real Estate Leasing, Contractual Work
To see the full contact details of KBD Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
KBD Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of KBD Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of KBD Pharmaceuticals Private Limited, buy the company report.
Financials of KBD Pharmaceuticals Private Limited
FY 2023 filings availableKBD Pharmaceuticals Private Limited reported revenue of ₹13.15 Lakh (up 10% YoY) for FY 2023.
Revenue · FY 2023
₹13.15 Lakh ▲ 10%
Net profit · FY 2023
₹72,090 margin 5.5%
EBITDA · FY 2023
₹1.07 Lakh margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 72%
5 years · compounded
▲ 80%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 95%
5 years · compounded
▲ 65%
Revenue has grown at a compounded annual rate (CAGR) of 80% over five years, including 10% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,090 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of KBD Pharmaceuticals Private Limited, buy the company report.
Board of directors of KBD Pharmaceuticals Private Limited
KBD Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puja Jyoti Kumari | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
| Barun Kumar | Director | 09 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
KBD Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fesochem Pharmaceuticals Private Limited | ₹13.17 Lakh (FY 2025) | -27.0% | Agra, Uttar Pradesh, India | |||
| KBD Pharmaceuticals Private Limitedthis company | ₹13.15 Lakh (FY 2023) | ₹72,090 | 5.5% | 10.0% | Hyderabad, Telangana, India | |
| Kestrel Pharmaceuticals Private Limited | ₹13.14 Lakh (FY 2025) | -26.0% | Jail Road, Kerala, India | |||
| Delmas Pharmaceuticals Private Limited | ₹13.12 Lakh (FY 2024) | 13.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of KBD Pharmaceuticals Private Limited, buy the company report.
Auditor
KBD Pharmaceuticals Private Limited is audited by M/s B.D. Saboo & Associates , Charted Accountants for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s B.D. Saboo & Associates , Charted Accountants | FY 2017 | 213530 |
Shareholding
The shareholding of KBD Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of KBD Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving KBD Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KBD Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for KBD Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
KBD Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Sardar Singh Charanjeet ceased to be Director on 28 Feb 2020.
AGM
Kbd Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Kbd Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ceased
Sardar Singh Charanjeet ceased to be Director.
Appointed
Puja Jyoti Kumari was appointed as Director.
Appointed
Barun Kumar was appointed as Director.
Incorporation
09 Dec 2014
Kbd Pharmaceuticals Private Limited was registered on 09 Dec 2014 with Roc Hyderabad & aged 11 years 10 months as per MCA records.
Frequently asked questions
KBD Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 09 December 2014 (12+ years old) and is registered under CIN U70100TG2014PTC096730.
KBD Pharmaceuticals has 2 current directors:
- Puja Jyoti Kumari - Director
- Barun Kumar - Director
The latest financial statements of KBD Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of KBD Pharmaceuticals is U70100TG2014PTC096730. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KBD Pharmaceuticals was incorporated on 09 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of KBD Pharmaceuticals by revenue are Fesochem Pharmaceuticals Private Limited, Kestrel Pharmaceuticals Private Limited, Delmas Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sardar Singh Charanjeet ceased to be Director on 28 Feb 2020. Puja Jyoti Kumari was appointed as Director on 13 Feb 2020. Barun Kumar was appointed as Director on 09 Dec 2014.
Yes, KBD Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0004365).
The registered office of KBD Pharmaceuticals is at 1 – 2 – 2121C3 Street No.11 Domalguda Suraj Nagar, Hyderabad, Telangana, India – 500029.
KBD Pharmaceuticals operates in the real estate industry, in the real estate leasing segment.
The compliance status of KBD Pharmaceuticals is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages